Science Explorer Back to mapMap
Discussion
Company · Golden · United States

PharmaJet (United States)

Research works
6
▲ 528% vs 2018-21
Citations
160
25.2 per fractional work
Top-10% rate
19.8%
all institutions 10.0%
Open access
81%
world 40%
International
51%
world 18%

Not ranked overall: PharmaJet (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PharmaJet (United States) work in?

In all years, 63% of research at PharmaJet (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (63%), Immunology and Microbiology (15%), Agricultural and Biological Sciences (13%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 62.6% of its workMedicine: 4 fractional works · 62.6% of its workEpidemiology: 2 fractional works · 25.9% of its workInfectious Diseases: 1 fractional works · 17.6% of its workEmergency Medicine: 1 fractional works · 8.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 3.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.7% of its workSurgery: 0 fractional works · 2.7% of its workLife Sciences: 2 fractional works · 36.8% of its workImmunology and Microbiology: 1 fractional works · 14.8% of its workImmunology: 0 fractional works · 6.9% of its workVirology: 0 fractional works · 6.1% of its workMicrobiology: 0 fractional works · 1.7% of its workAgricultural and Biological Sciences: 1 fractional works · 12.9% of its workAnimal Science and Zoology: 1 fractional works · 8.0% of its workAgronomy and Crop Science: 0 fractional works · 3.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 9.1% of its workMolecular Biology: 0 fractional works · 6.9% of its workEndocrinology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.6% of its workHealth: 0 fractional works · 0.6% of its workALL ITS WORKPharmaJet (UnitedStates)6fractional works, all years
Life Sciences37%Health Sciences63%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine462.6%
    1. Immunology and Microbiology114.8%
    2. Agricultural and Biological Sciences112.9%
    3. Biochemistry, Genetics and Molecular Biology19.1%
    1. Social Sciences00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at PharmaJet (United States)?

Ranked on the quality score, Michael A. Royals lead among researchers whose main affiliation is PharmaJet (United States).

  1. 1 Michael A. Royals United States · #1,505,513 worldwide 715 citations · 19 works
All ranked researchers at PharmaJet (United States)

What are the most cited papers from PharmaJet (United States)?

The most cited paper from PharmaJet (United States) is "Improved DNA Vaccine Delivery with Needle-Free Injection Systems" (Carmen Ledesma‐Feliciano, Rosamund E. Chapman, Jay W. Hooper et al., 2023), with 112 citations. Next come "Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial" (88) and "DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs" (56).

Most cited papers
#PaperReleasedCitations
1 Improved DNA Vaccine Delivery with Needle-Free Injection Systems Carmen Ledesma‐Feliciano, Rosamund E. Chapman, Jay W. Hooper et al. · Vaccines Open access 28 Jan 2023 112
2 Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial Linda McAllister, Jonathan Anderson, Kristen Werth et al. · The Lancet 31 May 2014 88
3 DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs J. Patrick Gorres, Kelly M. Lager, Wing-Pui Kong et al. · Clinical and Vaccine Immunology Open access 15 Sep 2011 56
4 Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies Alida Ault, Alyse M. Zajac, Wing-Pui Kong et al. · Vaccine Open access 23 Mar 2012 42
5 Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product Maria Dul et al. · Journal of Controlled Release Open access 8 Aug 2023 38
All 20 most cited papers, with filters and sorting

Which research topics does PharmaJet (United States) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies and Viral Infections and Outbreaks Research.

  1. 1 Immunotherapy and Immune Responses Immunology 0 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Hepatitis B Virus Studies Epidemiology 0 works
  4. 4 Viral Infections and Outbreaks Research Infectious Diseases 0 works
  5. 5 vaccines and immunoinformatics approaches Molecular Biology 0 works
  6. 6 Virology and Viral Diseases Epidemiology 0 works
  7. 7 Animal Virus Infections Studies Animal Science and Zoology 0 works
  8. 8 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  9. 9 Herpesvirus Infections and Treatments Epidemiology 0 works
  10. 10 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.3%not open18.7%

World: 40% of research is openly available.

with international co-authors51.4%domestic only48.6%

World: 18% is written across borders.

How has PharmaJet (United States)'s research output changed?

Output in 2022-2025 was 528% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PharmaJet (United States) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.000010%0.000020%0.000030%PharmaJet (United States)0.000018% in 20252020

Fractional works of PharmaJet (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Golden

All research institutions in Golden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PharmaJet (United States). Posts are plain text and can be reported.